This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new video webinar: PBMs and the Battle Over Patient Support Funds: Accumulators, Maximizers, and Alternative Funding This event will be broadcast live on Friday, June 23, 2023, from 12:00 p.m. We use Zoom technology for this webinar.
On October 5, 2021, Drug Channels Institute will release The 2021–22 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. pharmaceutical distribution industry. This report—our twelfth edition— remains the most comprehensive, fact-based tool for understanding and analyzing the large and growing U.S. to 1:30 p.m.
The integration of AI-powered market intelligence offers pharmaceutical companies a competitive edge by enabling real-time insights, predictive analytics, and strategic decision-making. Join us to gain valuable insights into how pharmaceutical companies can leverage AI to achieve more with less.
Trust Transformed: Pharma Marketing in the Post-Cookie Era dwunderlin Tue, 05/07/2024 - 13:29 Tue, 06/11/2024 - 14:00 Resource Type Webinar David Minkin Clifton Covey Sonia V Gupta Duration 60 Minutes In the backdrop of digital advertising for pharmaceuticals we are undergoing a radical transformation as privacy becomes a paramount concern.
Fein, president of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCI’s new live video webinar: The 340B Drug Pricing Program: Trends, Controversies, and Outlook This event will be broadcast live on Friday, June 21, 2024, from 12:00 p.m. to 1:30 p.m.
Join us for an exclusive webinar where well guide you through the essential steps of meeting Japans regulations and strict quality requirement. Join us for an exclusive webinar where well guide you through the essential steps of meeting Japans regulations and strict quality requirement. Register now to secure your spot.
The Unfiltered Truth about AI & Pharma Marketing dwunderlin Wed, 08/07/2024 - 12:04 Wed, 09/04/2024 - 14:00 Resource Type Webinar Chris Cullmann Doug Barr Promotion Start Thu, 08/08/2024 - 15:00 Promotion End Sat, 02/08/2025 - 15:00 Duration 60 Minutes You need to know where artificial intelligence disrupts the pharmaceuticalmarketing norms.
This week, I’m rerunning some popular posts while I put the finishing touches on DCI's new 2023-24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. During the full 90-minute webinar, I discussed seven crucial risks that could disrupt this market along with many other aspects of this emerging market.
In Cardinal’s 2021 fiscal year, CVS purchased more than $42 billion in pharmaceuticals from the wholesaler—about double the figure from 10 years ago. The two wholesalers sell more than $90 billion in pharmaceuticals to CVS Health—making it the largest U.S. drug purchaser. to 1:30 p.m.
So, how can pharmaceutical and biotech companies enter this market, and how can EAPs support and facilitate future successful commercialization? This webinar will delve into the benefits of Expanded Access Programs in Europe. Click here to login. Listing Image Sciensus_ListingLogo_250x190.png
Patient Content Marketing 2.0: As AI matures, it offers a transformative toolkit for pharma marketers to not only ideate and produce content efficiently but also deliver it with precision to the right patient at the right time. How generative AI is shaping the creative process, enabling marketers to rapidly ideate and build campaigns.
This week, I’m rerunning some popular posts while I prepare for today's live video webinar: Specialty Drugs Update: Trends, Controversies, and Outlook. Note that the forecasts below did not account for policy changes that could further reduce pharmaceuticals' share of U.S. healthcare spending. healthcare spending.
In this on-demand webinar, Ingrid Holmes , Vice President of Global Clinical Operations at Altasciences, and Dr. Gary G. Various psychomotor and neuropsychological tests, including the measurement of reaction time, divided attention, selective attention, and memory, may still be appropriate.
What’s more, taxpayers—via Medicare and Medicaid—will continue to crowd out the private insurance market. Thus, the government actuaries expect that pharmaceuticals will not be the key driver of U.S. One bright spot: consumers will account for an ever-smaller share of drug spending. healthcare spending growth. to 1:30 p.m.
Join this webinar to learn how supply forecasting and interactive response technology can help biotech companies improve supply planning and distribution while reducing cost and risk. In this webinar you will:
Master how to optimize supply planning and distribution by using supply forecasting and IRT.
7am PDT.
In recent years, each of these companies has launched new group purchasing organizations (GPOs) to further consolidate the number of covered lives in rebate negotiations with pharmaceutical manufacturers. Today, I examine these PBM-owned GPOs and then speculate on five plausible explanations for their existence. to 1:30 p.m.
This week, I’m rerunning some popular posts while we put the finishing touches on DCI’s new 2024-25 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. The 340B contract pharmacy market shows little sign of slowing down. For an updated look at what’s next for the 340B contract pharmacy market, join Adam J.
Roadmap to Product Launch and Commercialization in Europe pesurya Thu, 04/03/2025 - 10:38 Wed, 05/21/2025 - 11:00 Resource Type Webinar Marie-Charlotte von Brevern Eva Keck Chris Englerth Europe presents a dynamic and growing market for U.S. companies seeking to expand their reach and to bring innovative treatments to patients.
This webinar will feature industry leaders discussing how to deepen insights into patient behaviors while safeguarding privacy. They’ll explore the benefits of a holistic, patient-centered strategy that embraces diverse patient needs, driving more timely treatments and maximizing the impact of marketing efforts. Click here to login.
This webinar will explore innovative Direct-to-Patient cash solutions as a way to improve accessibility, convenience, and patient outcomes. Don't miss this opportunity to learn how pharma organizations can retain market share, increase overall profitability and boost their brand's gross to net. Click here to login.
The pharmaceutical industry is currently experiencing a significant transformation. Our comprehensive approach, integrating various aspects of drug development, such as clinical development, post-approval activities and market access, ensures optimal utilization of tools and strategies.
Exploring how digital transformation will revolutionize process optimization and decision-making within the pharmaceutical industry Networked digital technologies and advanced automation are transforming pharmaceutical manufacturing , enabling efficiencies through real-time process optimization and faster decision-making.
Developing and Manufacturing Minitablets to Extend Drug Lifecycle pesurya Fri, 01/12/2024 - 12:38 Wed, 02/28/2024 - 11:00 Resource Type Webinar Robert Strickley, PhD Valjon Demiri, MSc Duration 60 Minutes Oral minitablets can offer several advantages in pharmaceutical applications, making them a valuable option in drug delivery.
In this role, he will lead ELRIGs mission to foster collaboration, innovation, and knowledge-sharing through scientific conferences, networking events, webinars, and digital content. Dr Trezise succeeds Melanie Leveridge, who successfully completed her four-year term as Chair.
A wide range of other meetings that will be occurring this month, with various webinars, committee meetings, and workshops spanning a variety of topics. Upcoming Webinar Hosted by Xtalks Webinar/Seminar ( OPEN) Xtalks 11/6/2023 11/6/2023 What is the evidence for high-risk medical devices in the field of cardiovascular disease and diabetes?
This week, I’m rerunning some popular posts while I prepare for today's live video webinar: Drug Channels Quarterly Update: Patients, Payers, and PBMs. on the overall market, explained channel distortions from 340B contract pharmacies, and offered some policy recommendations. I shared my $0.02
Several webinars and training sessions are geared towards ISO identification of medicinal products (IDMP) standards which is referred to as Substance, Product, Organization, Referentials (SPOR) data management services. The European Council held its first public debate of the proposed pharmaceutical legislation last week.
We respect your privacy, by clicking “Download Your Copy” you will receive our e-newsletter, including information on Podcasts, Webinars, event discounts,
online learning opportunities and agree to our User Agreement. Add bookmark. Download Your Copy.
You have the right to object.
Download Your Copy.
Many of these webinars and trainings sessions are geared towards medical devices and in vitro diagnostics (IVDs). There will also be a number of noteworthy conferences taking place this month pertaining to the vaccine and medical technology industries.
The 340B Drug Pricing Program continues to expand far more quickly than the overall pharmaceuticalmarket—and some channels are benefiting more than others. That’s about six times faster than the overall mail and specialty market. Consequently, specialty pharmacies have gained a greater share of the 340B market.
During 2020, the COVID-19 pandemic disrupted every aspect of the pharmaceutical channel—and our lives. Pharmacy and healthcare provider markets experienced unprecedented volatility. Pharmaceutical wholesalers have maintained shipments and operational capacity. This year has demonstrated the underlying resilience of U.S.
As the pharma community continue to research and develop hundreds of potential therapies to combat the Covid-19 pandemic, very few initiatives are yet to cross the finishing line into the commercial market. REGN -COV2 could be a critical line of defense against the Covid-19 pandemic.”. Sign up now.
European Parliament negotiations on the proposed regulation and directive to overhaul the pharmaceutical legislation are ongoing. Although our POLITICO Pro EU colleagues have provided some updates, the discussions are held behind closed doors.
Many of these are webinars and/or trainings sessionsfor new digital platforms. voted to adopt the compromise texts of both the revised pharmaceutical directive and regulation presented by Parliament’s health committee in March 2024. This month will also see several large, multi-day conferences hosted by public and private stakeholders.
This will include a number of conferences, webinars, and training sessions, as well as a long-awaited EMA workshop on psychedelics. Perhaps the most significant pharmaceutical news anticipated for April: the vote on the pharmaceutical legislation revision.
ELRIG aims to bring the life science and drug discovery communities together to learn, share, connect, innovate, and collaborate, on an open-access basis through the provision of conferences, networking events, webinars, and digital content.
The International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) has made strides in standardizing technical requirements to streamline pharmaceutical development on a global scale. Each nation has varying definitions of what qualifies as a pivotal study. Japan, and China. and the U.S.
One dose of the Sputnik V vaccine will cost less than $10 for international markets. The Russian Direct Investment Fund (RDIF) has announced the cost of the Russian Sputnik V vaccine for international markets will cost less than US$10 per dose and will be free of charge for all Russian citizens. Source link.
Drive Engagement and Segmentation for Physician Marketing With the proliferation of digital media, marketing in the healthcare industry has shifted from traditional tactics to an omnichannel approach. With an omnichannel approach, pharma marketers can have a better understanding of HCP interests and preferences.
Major European regulators, national competent authorities, and interest groups are planning on hosting several webinars and trainings throughout August and September. Speaking of policy, legislative affairs will also likely pick up.
In the now distant past, enforcement from this office, then called the Division of Drug Marketing, Advertising, and Communications (DDMAC) and later re-named OPDP, was robust, with the office issuing scores of letters a year (156 were issued in 1998). This item disappeared from the agenda, however, and no draft guidance was issued.
The World Health Organization (WHO) webinar on One Health and GVCR (18 November) focused on integration of neglected zoonotic diseases, vector?borne The full recording of this webinar is available on YouTube. The next NTD webinar on 2 December 2020 is about partnership. Registration is open. . Source link.
CSE: BHSC) (the “Company” or “BioHarvest”) invites its shareholders and the general public to join a Live Video Conference (“Webinar”) on Thursday, January 21st, 2021 at 2:00 PM Eastern Standard Time (11:00 AM Pacific Standard Time). . – January 20, 2021) – BioHarvest Sciences Inc.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content